Cargando…

Benefit of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reaction

BACKGROUND: Mediastinal lymphadenopathy in combination with lung cancer is suggestive for lymph node metastases but can also have other origins. CASE REPORT: We describe a patient diagnosed with stage IV lung cancer presenting with parenchymal lesions and enlarged mediastinal lymph nodes. A second o...

Descripción completa

Detalles Bibliográficos
Autores principales: Schook, Romane M., Koudstaal, Lyan, Comans, Emile F., Postmus, Pieter E., Grünberg, Katrien, Paul, Marinus A., Smit, Egbert F., Sutedja, Thomas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246249/
https://www.ncbi.nlm.nih.gov/pubmed/26029554
http://dx.doi.org/10.1016/j.rmcr.2014.07.002
Descripción
Sumario:BACKGROUND: Mediastinal lymphadenopathy in combination with lung cancer is suggestive for lymph node metastases but can also have other origins. CASE REPORT: We describe a patient diagnosed with stage IV lung cancer presenting with parenchymal lesions and enlarged mediastinal lymph nodes. A second opinion including FDG-PET scan review and a mediastinoscopy followed by surgery revealed tumor specimens originating from a single primary tumor with a sarcoid-like reaction in the mediastinal lymph nodes, changing the diagnosis from metastasized to resectable lung cancer. DISCUSSION: PET positive lesions are not always synonymous with metastatic disease in the presence of a malignant tumor. Conscientious review of FDG-PET scans and tissue sampling are therefore mandatory to determine definitive staging and subsequent interventions.